Literature DB >> 18381614

Bacteria and bacterial rRNA genes associated with the development of colitis in IL-10(-/-) mice.

Jingxiao Ye1, Jimmy W Lee2, Laura L Presley1, Elizabeth Bent1, Bo Wei3, Jonathan Braun3, Neal L Schiller2, Daniel S Straus2, James Borneman1.   

Abstract

BACKGROUND: Microorganisms appear to play important yet ill-defined roles in the etiology of inflammatory bowel disease (IBD). This study utilized a novel population-based approach to identify bacteria and bacterial rRNA genes associated with the development of colitis in IL-10(-/-) mice.
METHODS: Mice were housed in 2 environments: a community mouse facility where the mice were fed nonsterile chow (Room 3) and a limited access facility where the mice were fed sterile chow (Room 4). Every month the disease activity levels were assessed and fecal bacterial compositions were analyzed. At the end of the experiments histological and bacterial analyses were performed on intestinal tissue.
RESULTS: Although disease activity increased over time in both environments, it progressed at a faster rate in Room 3 than Room 4. Culture and culture-independent bacterial analyses identified several isolates and phylotypes associated with colitis. Two phylotypes (GpC2 and Gp66) were distinguished by their negative associations with disease activity in fecal and tissue samples. Notably, rRNA genes from these phylotypes had high sequence identity (99%) to an rRNA gene from a previously described flagellated Clostridium (Lachnospiraceae bacterium A4).
CONCLUSIONS: The negative associations of these 2 phylotypes (GpC2 and Gp66) suggest that these bacteria were being immunologically targeted, consistent with prior findings that the Lachnospiraceae bacterium A4 bears a prevalent flagellar antigen for disease-associated immunity in murine immune colitis and human Crohn's disease. Identification of these associations suggests that the experimental approach used in this study will have considerable utility in elucidating the host-microbe interactions underlying IBD.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18381614      PMCID: PMC3804113          DOI: 10.1002/ibd.20442

Source DB:  PubMed          Journal:  Inflamm Bowel Dis        ISSN: 1078-0998            Impact factor:   5.325


  55 in total

1.  Effect of faecal stream diversion on recurrence of Crohn's disease in the neoterminal ileum.

Authors:  P Rutgeerts; K Goboes; M Peeters; M Hiele; F Penninckx; R Aerts; R Kerremans; G Vantrappen
Journal:  Lancet       Date:  1991-09-28       Impact factor: 79.321

2.  PRISE (PRImer SElector): software for designing sequence-selective PCR primers.

Authors:  Qi Fu; Paul Ruegger; Elizabeth Bent; Marek Chrobak; James Borneman
Journal:  J Microbiol Methods       Date:  2007-12-23       Impact factor: 2.363

3.  Double blind, placebo controlled trial of metronidazole in Crohn's disease.

Authors:  L Sutherland; J Singleton; J Sessions; S Hanauer; E Krawitt; G Rankin; R Summers; H Mekhjian; N Greenberger; M Kelly
Journal:  Gut       Date:  1991-09       Impact factor: 23.059

4.  Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration.

Authors:  B J Marshall; J R Warren
Journal:  Lancet       Date:  1984-06-16       Impact factor: 79.321

5.  Reduction in diversity of the colonic mucosa associated bacterial microflora in patients with active inflammatory bowel disease.

Authors:  S J Ott; M Musfeldt; D F Wenderoth; J Hampe; O Brant; U R Fölsch; K N Timmis; S Schreiber
Journal:  Gut       Date:  2004-05       Impact factor: 23.059

6.  Interleukin-10-deficient mice develop chronic enterocolitis.

Authors:  R Kühn; J Löhler; D Rennick; K Rajewsky; W Müller
Journal:  Cell       Date:  1993-10-22       Impact factor: 41.582

7.  Genotypic and phenotypic studies of murine intestinal lactobacilli: species differences in mice with and without colitis.

Authors:  J A Peña; S Y Li; P H Wilson; S A Thibodeau; A J Szary; J Versalovic
Journal:  Appl Environ Microbiol       Date:  2004-01       Impact factor: 4.792

8.  Bacterial flagellin is a dominant antigen in Crohn disease.

Authors:  Michael J Lodes; Yingzi Cong; Charles O Elson; Raodoh Mohamath; Carol J Landers; Stephan R Targan; Madeline Fort; Robert M Hershberg
Journal:  J Clin Invest       Date:  2004-05       Impact factor: 14.808

9.  Impairment of bacterial flora in human ulcerative colitis and experimental colitis in the rat.

Authors:  R Fabia; A Ar'Rajab; M L Johansson; R Andersson; R Willén; B Jeppsson; G Molin; S Bengmark
Journal:  Digestion       Date:  1993       Impact factor: 3.216

Review 10.  Therapeutic manipulation of the enteric microflora in inflammatory bowel diseases: antibiotics, probiotics, and prebiotics.

Authors:  R Balfour Sartor
Journal:  Gastroenterology       Date:  2004-05       Impact factor: 22.682

View more
  23 in total

1.  Bifidobacterium animalis subsp. lactis fermented milk product reduces inflammation by altering a niche for colitogenic microbes.

Authors:  Patrick Veiga; Carey Ann Gallini; Chloé Beal; Monia Michaud; Mary L Delaney; Andrea DuBois; Artem Khlebnikov; Johan E T van Hylckama Vlieg; Shivesh Punit; Jonathan N Glickman; Andrew Onderdonk; Laurie H Glimcher; Wendy S Garrett
Journal:  Proc Natl Acad Sci U S A       Date:  2010-10-04       Impact factor: 11.205

2.  Individuality in gut microbiota composition is a complex polygenic trait shaped by multiple environmental and host genetic factors.

Authors:  Andrew K Benson; Scott A Kelly; Ryan Legge; Fangrui Ma; Soo Jen Low; Jaehyoung Kim; Min Zhang; Phaik Lyn Oh; Derrick Nehrenberg; Kunjie Hua; Stephen D Kachman; Etsuko N Moriyama; Jens Walter; Daniel A Peterson; Daniel Pomp
Journal:  Proc Natl Acad Sci U S A       Date:  2010-10-11       Impact factor: 11.205

Review 3.  The role of mucosal immunity and host genetics in defining intestinal commensal bacteria.

Authors:  Jonathan Hansen; Ajay Gulati; R Balfour Sartor
Journal:  Curr Opin Gastroenterol       Date:  2010-11       Impact factor: 3.287

4.  Phylotype-level 16S rRNA analysis reveals new bacterial indicators of health state in acute murine colitis.

Authors:  David Berry; Clarissa Schwab; Gabriel Milinovich; Jochen Reichert; Karim Ben Mahfoudh; Thomas Decker; Marion Engel; Brigitte Hai; Eva Hainzl; Susanne Heider; Lukas Kenner; Mathias Müller; Isabella Rauch; Birgit Strobl; Michael Wagner; Christa Schleper; Tim Urich; Alexander Loy
Journal:  ISME J       Date:  2012-05-10       Impact factor: 10.302

5.  Novel anti-inflammatory functions for endothelial and myeloid cyclooxygenase-2 in a new mouse model of Crohn's disease.

Authors:  Junji Watanabe; James A Lin; Ajay J Narasimha; Ani Shahbazian; Tomo-O Ishikawa; Martin G Martin; Harvey R Herschman; Srinivasa T Reddy
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2010-03-18       Impact factor: 4.052

6.  Lactobacillus reuteri maintains a functional mucosal barrier during DSS treatment despite mucus layer dysfunction.

Authors:  Johan Dicksved; Olof Schreiber; Ben Willing; Joel Petersson; Sara Rang; Mia Phillipson; Lena Holm; Stefan Roos
Journal:  PLoS One       Date:  2012-09-27       Impact factor: 3.240

7.  Chimpanzees and humans harbour compositionally similar gut enterotypes.

Authors:  Andrew H Moeller; Patrick H Degnan; Anne E Pusey; Michael L Wilson; Beatrice H Hahn; Howard Ochman
Journal:  Nat Commun       Date:  2012       Impact factor: 14.919

8.  Improving probe set selection for microbial community analysis by leveraging taxonomic information of training sequences.

Authors:  Paul M Ruegger; Gianluca Della Vedova; Tao Jiang; James Borneman
Journal:  BMC Bioinformatics       Date:  2011-10-10       Impact factor: 3.169

9.  Expression of the blood-group-related glycosyltransferase B4galnt2 influences the intestinal microbiota in mice.

Authors:  Fabian Staubach; Sven Künzel; Andrea C Baines; Andrew Yee; Beth M McGee; Fredrik Bäckhed; John F Baines; Jill M Johnsen
Journal:  ISME J       Date:  2012-01-26       Impact factor: 10.302

10.  Plasma levels of trimethylamine-N-oxide can be increased with 'healthy' and 'unhealthy' diets and do not correlate with the extent of atherosclerosis but with plaque instability.

Authors:  Yen Chin Koay; Yung-Chih Chen; Jibran A Wali; Alison W S Luk; Mengbo Li; Hemavarni Doma; Rosa Reimark; Maria T K Zaldivia; Habteab T Habtom; Ashley E Franks; Gabrielle Fusco-Allison; Jean Yang; Andrew Holmes; Stephen J Simpson; Karlheinz Peter; John F O'Sullivan
Journal:  Cardiovasc Res       Date:  2021-01-21       Impact factor: 10.787

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.